Haemonetics CorporationHAENYSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR-77.6%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-77.6%/yr
vs +51.6%/yr prior
Acceleration
-129.2pp
Decelerating
Percentile
P50
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
20250.29%
202412.53%
202312.57%
202225.92%
2021-0.94%
2020-10.71%
2019-5.76%
20184.90%
2017-4.89%
2016-6.61%